511 related articles for article (PubMed ID: 17407446)
1. Activation of NADPH oxidase by transforming growth factor-beta in hepatocytes mediates up-regulation of epidermal growth factor receptor ligands through a nuclear factor-kappaB-dependent mechanism.
Murillo MM; Carmona-Cuenca I; Del Castillo G; Ortiz C; Roncero C; Sánchez A; Fernández M; Fabregat I
Biochem J; 2007 Jul; 405(2):251-9. PubMed ID: 17407446
[TBL] [Abstract][Full Text] [Related]
2. EGF blocks NADPH oxidase activation by TGF-beta in fetal rat hepatocytes, impairing oxidative stress, and cell death.
Carmona-Cuenca I; Herrera B; Ventura JJ; Roncero C; Fernández M; Fabregat I
J Cell Physiol; 2006 May; 207(2):322-30. PubMed ID: 16331683
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1-dependent activation of the metalloprotease TACE/ADAM17 by TGF-β in hepatocytes requires activation of Src and the NADPH oxidase NOX1.
Moreno-Càceres J; Mainez J; Mayoral R; Martín-Sanz P; Egea G; Fabregat I
FEBS J; 2016 Apr; 283(7):1300-10. PubMed ID: 26815118
[TBL] [Abstract][Full Text] [Related]
4. The inhibition of the epidermal growth factor (EGF) pathway enhances TGF-beta-induced apoptosis in rat hepatoma cells through inducing oxidative stress coincident with a change in the expression pattern of the NADPH oxidases (NOX) isoforms.
Sancho P; Bertran E; Caja L; Carmona-Cuenca I; Murillo MM; Fabregat I
Biochim Biophys Acta; 2009 Feb; 1793(2):253-63. PubMed ID: 18848961
[TBL] [Abstract][Full Text] [Related]
5. Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes.
Murillo MM; del Castillo G; Sánchez A; Fernández M; Fabregat I
Oncogene; 2005 Jun; 24(28):4580-7. PubMed ID: 15856020
[TBL] [Abstract][Full Text] [Related]
6. Differential intracellular signalling induced by TGF-beta in rat adult hepatocytes and hepatoma cells: implications in liver carcinogenesis.
Caja L; Ortiz C; Bertran E; Murillo MM; Miró-Obradors MJ; Palacios E; Fabregat I
Cell Signal; 2007 Apr; 19(4):683-94. PubMed ID: 17055226
[TBL] [Abstract][Full Text] [Related]
7. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
8. TLR-4 signalling accelerates colon cancer cell adhesion via NF-κB mediated transcriptional up-regulation of Nox-1.
O'Leary DP; Bhatt L; Woolley JF; Gough DR; Wang JH; Cotter TG; Redmond HP
PLoS One; 2012; 7(10):e44176. PubMed ID: 23071493
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta-induced p38 activation is mediated by Rac1-regulated generation of reactive oxygen species in cultured human keratinocytes.
Chiu C; Maddock DA; Zhang Q; Souza KP; Townsend AR; Wan Y
Int J Mol Med; 2001 Sep; 8(3):251-5. PubMed ID: 11494050
[TBL] [Abstract][Full Text] [Related]
10. HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells.
Uttarwar L; Peng F; Wu D; Kumar S; Gao B; Ingram AJ; Krepinsky JC
Am J Physiol Renal Physiol; 2011 Apr; 300(4):F921-31. PubMed ID: 21289053
[TBL] [Abstract][Full Text] [Related]
11. RhoA/Rho kinase mediates TGF-β1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species.
Manickam N; Patel M; Griendling KK; Gorin Y; Barnes JL
Am J Physiol Renal Physiol; 2014 Jul; 307(2):F159-71. PubMed ID: 24872317
[TBL] [Abstract][Full Text] [Related]
12. Involvement of HB-EGF and EGF receptor transactivation in TGF-beta-mediated fibronectin expression in mesangial cells.
Uchiyama-Tanaka Y; Matsubara H; Mori Y; Kosaki A; Kishimoto N; Amano K; Higashiyama S; Iwasaka T
Kidney Int; 2002 Sep; 62(3):799-808. PubMed ID: 12164862
[TBL] [Abstract][Full Text] [Related]
13. NADPH oxidase NOX1 controls autocrine growth of liver tumor cells through up-regulation of the epidermal growth factor receptor pathway.
Sancho P; Fabregat I
J Biol Chem; 2010 Aug; 285(32):24815-24. PubMed ID: 20525691
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 is required for TGF-β-induced transactivation of the EGF receptor pathway in hepatocytes through the activation of the metalloprotease TACE/ADAM17.
Moreno-Càceres J; Caja L; Mainez J; Mayoral R; Martín-Sanz P; Moreno-Vicente R; Del Pozo MÁ; Dooley S; Egea G; Fabregat I
Cell Death Dis; 2014 Jul; 5(7):e1326. PubMed ID: 25032849
[TBL] [Abstract][Full Text] [Related]
15. Insulin-induced activation of hypoxia-inducible factor-1 requires generation of reactive oxygen species by NADPH oxidase.
Biswas S; Gupta MK; Chattopadhyay D; Mukhopadhyay CK
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H758-66. PubMed ID: 17085541
[TBL] [Abstract][Full Text] [Related]
16. Transactivation of epidermal growth factor receptor mediates catecholamine-induced growth of vascular smooth muscle.
Zhang H; Chalothorn D; Jackson LF; Lee DC; Faber JE
Circ Res; 2004 Nov; 95(10):989-97. PubMed ID: 15486316
[TBL] [Abstract][Full Text] [Related]
17. EGFR is dispensable for c-Met-mediated proliferation and survival activities in mouse adult liver oval cells.
Martínez-Palacián A; Del Castillo G; Herrera B; Fernández M; Roncero C; Fabregat I; Sánchez A
Cell Signal; 2012 Feb; 24(2):505-513. PubMed ID: 22001397
[TBL] [Abstract][Full Text] [Related]
18. Early NADPH oxidase-2 activation is crucial in phenylephrine-induced hypertrophy of H9c2 cells.
Hahn NE; Musters RJ; Fritz JM; Pagano PJ; Vonk AB; Paulus WJ; van Rossum AC; Meischl C; Niessen HW; Krijnen PA
Cell Signal; 2014 Sep; 26(9):1818-24. PubMed ID: 24794531
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-α-induced nuclear factor-kappaB activation in human cardiomyocytes is mediated by NADPH oxidase.
Moe KT; Khairunnisa K; Yin NO; Chin-Dusting J; Wong P; Wong MC
J Physiol Biochem; 2014 Sep; 70(3):769-79. PubMed ID: 25059721
[TBL] [Abstract][Full Text] [Related]
20. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
